EQS-Adhoc
European Healthcare Acquisition & Growth Company B.V. announces change in CEO position
- EHC announces CEO change: Dr. Baur resigns, Dr. Rudolph appointed as new CEO and compliance officer.
- EHC is a healthcare-focused SPAC in Europe with innovative investment opportunities.
- Forward-looking statements in the release, risks and uncertainties involved.
EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Personnel Public disclosure of inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation) |
European Healthcare Acquisition & Growth Company B.V. announces change in CEO position
Munich, May 2, 2024
European Healthcare Acquisitions & Growth Company B.V. (“EHC”) received the resignation letter from Dr. Cornelius H. Baur as an executive director, the chief executive officer (“CEO”) and the compliance officer of EHC with immediate effect, as he would like to pursue another supervisory board position of a listed company. The remaining five members of EHC’s board of directors today appointed the current chief investment officer and now sole executive director, Dr. Thomas Rudolph, also as CEO and compliance officer. Stefan Winners, chairman of the board, Peer M. Schatz, Dr. Stefan Oschmann and Dr. Axel Herberg remain non-executive directors of EHC.
-----------
About EHC
EHC is an operators-led special purpose acquisition company. With its exclusive focus on healthcare, EHC is the first of its kind in Europe and benefits from excellent investment opportunities driven by the market’s underlying fundamentals and an excellent value creation potential. In addition, the Sponsors have created a novel structure which materially innovates the special purpose vehicle concept to allow a very attractive alignment of interests of all stakeholders.